| News

Sotio opens office in Basel

09.01.2020

The Czech biotech company Sotio has opened an office in the Technologiepark Basel. Sotio Biotech AG will be responsible for the company’s clinical development.

Biotech (img: angellodeco/shutterstock)

BaselArea.swiss has persuaded another company of the benefits of the Basel region. The location promotion organization helped Sotio open an office in the Technologiepark Basel. In a statement, the Czech biotech company cited Basel’s reputation as a top center for life sciences with a global reach as reasons for its choice. Sotio also highlighted Basel’s very attractive business environment and biotechnology talent pool, stating that it plans to add top professionals to its team.

Sotio is part of the PPF Group. Both companies work in cell therapy and are following the strategy to expand their product portfolio to include new immuno-oncology drugs. Sotio Biotech AG will host clinical development in Basel, as well as functions in marketing authorization and commercial launch. With its new office, Sotio is strengthening its presence in globally-recognized biotech hubs, according to Radek Spisek, CEO of SOTIO.

The Czech company has already worked with other companies from Basel, including NBE-Therapeutics and Cellestia Biotech.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Invest

Ricola earns the trust of Switzerland

Ricola has been voted the most trustworthy brand in Switzerland. The manufacturer of herbal candy, which is based in the Basel Area, previously won this award in 2017.

Read More
Basel Area Business & Innovation, Innovation

docdok.health involved in coronavirus research project

A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.

Read More
Basel Area Business & Innovation, Innovation

Celonic agrees cooperation to combat coronavirus

The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.

Read More
Basel Area Business & Innovation, Innovation, Invest

Idorsia receives payment of 45 million US dollars

The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..

Read More
Basel Area Business & Innovation, Innovation

Humard robot disinfects using UV light

Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.

Read More
Basel Area Business & Innovation, Innovation, Invest

Roche authorized to distribute coronavirus antibody tests

Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.